Biotechnology · NYSE
ABBVAbbVie Inc.
- Last close
- $295.03 +0.2%
- 52-week range
- $190.75 to $302.93
- Market cap
- $521B
- Next earnings
- Not scheduled
Fiscal 2025 at a glance
Stock price
Valuation vs its own 10 years
Above its 10-year median on all 4 multiples
Where each multiple sits today inside its own range since 2016, measured at every quarter end. The thin tick is the median.
Key statistics
Trailing 12 months unless noted, through the quarter ending 2026-09-30. Every figure carries its unit.
Valuation
- P/E
- 50.8x
- Earnings yield
- 2.0%
- Price / sales
- 7.9x
- Price / book
- n/aNot reported
- Price / operating cash flow
- 26.0x
- EV / EBITDA
- 26.9x
- EV / sales
- 9.0x
- Free cash flow yield
- 3.6%
Profitability
- Gross margin
- 73.7%
- Operating margin
- 32.2%
- Net margin
- 15.7%
- Return on equity
- n/aNegative equity
- Return on capital
- 22.5%
Growth per year
- Revenue, 3 years
- +1.8%
- Revenue, 5 years
- +6.0%
- Revenue, 9 years
- +10.1%
- EPS, 3 years
- -29.1%
Balance sheet
- Cash and investments
- $10.8B
- Total debt
- $80.9B
- Net cash
- -$70.1B
- Debt / equity
- n/aNegative equity
- Current ratio
- 0.87x
Shares and dividend
- Shares outstanding
- 1.77B
- Share count, 5 years
- +6.0%
- Beta, 1 year
- -0.02
- Dividend yield
- 2.3%
- Dividend per share, TTM
- $6.92
- Payout ratio
- 117%
Ten years of the business
Last 40 quarters, fiscal 2016 to 2025 and after. Hover a bar for its quarter.
Fiscal years 2016 to 2025.
Biotechnology peers
The largest names in the same industry that we cover, all in US dollars. The last column applies the same history test to each peer.
| Company | Market cap | Revenue growth | Operating margin | P/E | P/S | P/E vs own history |
|---|---|---|---|---|---|---|
| ONC BeOne Medicines Ltd. | $619B | +33% | 17.8% | 689x | 93.6x | Not enough history |
| ABBV AbbVie Inc. | $521B | +11% | 32.2% | 50.8x | 7.9x | 72nd percentile |
| AMGN Amgen Inc | $252B | +8% | 32.4% | 27.0x | 6.5x | 78th percentile |
| GILD Gilead Sciences, Inc. | $208B | +7% | -7.6% | No earnings | 6.7x | No earnings |
| VRTX Vertex Pharmaceuticals Inc / Ma | $137B | +10% | 33.2% | 34.7x | 10.5x | 71st percentile |
| MRNA Moderna, Inc. | $90.4B | +13% | -116% | No earnings | 35.8x | No earnings |
The company
- Sector
- Health Care
- Industry
- Biotechnology
- CEO
- Richard A. Gonzalez
- Founded
- 2012
- Headquarters
- North Chicago, IL
- Fiscal year ends
- December
- Website
- abbvie.com
What it does
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
Description from Wikipedia (CC BY-SA).
Around the numbers
What the rest of EdgeStacker knows about ABBV.